ArticleJournal of animal science2023
Evaluation of a novel phytase derived from Citrobacter braakii and expressed in Aspergillis oryzae on growth performance and bone mineralization indicators in nursery pigs.
Article in Journal of animal science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A total of 297 pigs (DNA 241 × 600; initially 8.64 ± 0.181 kg) were used in a 21-d trial to determine the efficacy of a novel phytase derived from Citrobacter braakii and expressed in Aspergillis oryzae (HiPhorius; DSM Nutritional Products, Animal Nutrition & Health, Parsippany, NJ) on pig growth and bone mineralization indicators. Pens of pigs were assigned to 1 of 5 dietary treatments in a randomized complete block design with 5 pigs per pen and 12 pens per treatment. The trial was initiated 14-d after weaning. The first three treatments were formulated to contain 0.09% aP; without added phytase (control), or the control diet with 600 or 1,000 FYT/kg of added phytase (considering a release of 0.15% or 0.18% aP, respectively). The remaining two treatments were formulated to contain 0.27% aP, one without added phytase and the other with 1,000 FYT/kg. From days 0 to 21, pigs fed increasing phytase in diets containing 0.09% aP had increased (linear, P ≤ 0.002) ADG, ADFI, and G:F, but added phytase in the 0.27% aP diet did not impact growth performance. Increasing phytase in diets containing 0.09% aP increased percentage bone ash in metacarpals and 10th ribs (linear, P < 0.001; quadratic, P = 0.004, respectively), and increased grams of Ca and P in metacarpals, 10th ribs, and fibulas (linear, P ≤ 0.027). Adding 1,000 FYT/kg phytase in diets with 0.27% aP increased (P ≤ 0.05) percentage bone ash and grams of Ca and P in fibulas and 10th ribs compared with pigs fed 0.27% aP without added phytase. Increasing aP from 0.09% to 0.27% in diets without added phytase increased (P < 0.001) ADG, ADFI, and G:F. Increasing aP from 0.09% to 0.27% in diets without added phytase increased bone density (P ≤ 0.002) in fibulas and metacarpals, percentage bone ash in all bones (P ≤ 0.074), and increased (P < 0.05) grams of Ca and P in fibulas and 10th ribs. Pigs fed diets containing 0.09 or 0.27% aP, both with 1,000 FYT added phytase, had increased (P < 0.05) bone density in fibulas and metacarpals, percentage bone ash in all bones, and increased grams of Ca and P in fibulas and 10th ribs. For growth performance (average of ADG and G:F), aP release was calculated to be 0.170% for 600 FYT/kg and 0.206% for 1,000 FYT/kg. For the average of all bone measurements (average of 3 bones for both bone density and percentage bone ash), aP release was calculated to be 0.120% and 0.125% for 600 and 1,000 FYT/kg, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.